Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Other Non-Current Assets (2016 - 2024)

BioRestorative Therapies (BRTX) has disclosed Other Non-Current Assets for 9 consecutive years, with $22381.0 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Other Non-Current Assets changed N/A year-over-year to $22381.0, compared with a TTM value of $22381.0 through Jun 2024, changed N/A, and an annual FY2018 reading of $22100.0, changed 0.0% over the prior year.
  • Other Non-Current Assets was $22381.0 for Q2 2024 at BioRestorative Therapies, up from $9538.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $22381.0 in Q2 2024 and bottomed at $9538.0 in Q1 2024.